Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02587026 · ClinicalTrials.gov registry record
Biorepository for Precision Genomics
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 480
- Enrollment target
NCT02587026: Clinical Trial study, sponsored by Indiana University.
NCT02587026 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 480 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02587026 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 480 participants
- Enrollment target
Study Summary
This is a tissue collection protocol to create an annotated biorepository to support future basic and translational research. The study protocol and consent will request patient permission to allow their specimens to be stored for future use in other laboratory/correlative studies without requiring a separate new consent at a future date. It will include also a retrospective review of all patients who have been seen or treated by the Precision Genomics Clinic (waiver of consent requested). No specific research studies/aims are included directly in this proposal. Use of the samples, data, and other resources (cell lines, etc.) created within this protocol will require review/approval by the majority of the Precision Genomics Investigators and appropriate IRB approval.
Primary Outcome
Blood and tissue sample collection for use in future basic and translational research studies
Interventions
- OTHER Blood sample collection
- OTHER Tumor tissue sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2015-08-27 |
| Est. Completion | 2020-07-07 |
Why NCT02587026 stopped before completion
NCT02587026 is an observational study that tracks outcomes without assigning an intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Blood sample collection is the first listed.
NCT02587026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02587026 about?
NCT02587026 is a clinical study titled "Biorepository for Precision Genomics". This is a tissue collection protocol to create an annotated biorepository to support future basic and translational research. The study protocol and consent will request patient permission to allow their specimens to be stored for future use in other laboratory/correlative studies without requiring ...
What is the current status of trial NCT02587026?
This trial is currently terminated. The enrollment target is 480 participants. The study started on 2015-08-27. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT02587026?
The interventions under investigation include: Blood sample collection (OTHER), Tumor tissue sample collection (OTHER).
Who is sponsoring clinical trial NCT02587026?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI